Literature DB >> 3016026

Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

G C Nicholson, J M Moseley, P M Sexton, F A Mendelsohn, T J Martin.   

Abstract

Calcitonin receptors have been characterized for the first time in isolated osteoclasts. These receptors have been demonstrated by autoradiographic and biochemical methods, and the cells have also been shown to respond to calcitonin with a dose-dependent increase in cyclic AMP. The receptors in rat osteoclasts are specific and of high affinity (dissociation constant, Kd, 1 to 6 X 10(-10) M), and are present in greater numbers than in any cell previously studied (greater than 10(6) per cell). Chemical cross-linking of 125I-labeled salmon calcitonin to osteoclasts using disuccinimidyl suberate resulted in identification of a receptor component with a relative molecular weight of 80,000-90,000. By counting grains in autoradiographic experiments, we found that greater than 80% of specifically bound radioactivity was associated with multinucleate osteoclasts and the remainder was associated with mononuclear cells that are not osteoblasts, but that may be osteoclast precursors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016026      PMCID: PMC423551          DOI: 10.1172/JCI112584

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressin.

Authors:  S R Goldring; J M Dayer; D A Ausiello; S M Krane
Journal:  Biochem Biophys Res Commun       Date:  1978-07-28       Impact factor: 3.575

2.  Radioimmunoassay for the measurement of cyclic nucleotides.

Authors:  A L Steiner; R E Wehmann; C W Parker; D M Kipnis
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

3.  Calcitonin receptors on cultured human lymphocytes.

Authors:  S J Marx; G D Aurbach; J R Gavin; D W Buell
Journal:  J Biol Chem       Date:  1974-11-10       Impact factor: 5.157

4.  Renal receptors for calcitonin. Binding and degradation of hormone.

Authors:  S J Marx; C Woodward; G D Aurbach; H Glossmann; H T Keutmann
Journal:  J Biol Chem       Date:  1973-07-10       Impact factor: 5.157

5.  Thyrocalcitonin: inhibitor of bone resorption in tissue culture.

Authors:  J Friedman; L G Raisz
Journal:  Science       Date:  1965-12-10       Impact factor: 47.728

6.  The effects of calcitonin, parathyroid hormone and prostaglandin E2 on cyclic AMP levels of isolated osteoclasts.

Authors:  M B Ito; H Schraer; C V Gay
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1985

7.  Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts.

Authors:  R A Luben; G L Wong; D V Cohn
Journal:  Endocrinology       Date:  1976-08       Impact factor: 4.736

8.  Acute effects of calcitonin on osteoclasts in man.

Authors:  F R Singer; K E Melvin; B G Mills
Journal:  Clin Endocrinol (Oxf)       Date:  1976       Impact factor: 3.478

9.  Analogues of human calcitonin. IV. Influence of leucine substitutions in positions 12, 16 and 19 on hypocalcaemic activity in the rat.

Authors:  R Maier; B Kamber; B Riniker; W Rittel
Journal:  Clin Endocrinol (Oxf)       Date:  1976       Impact factor: 3.478

10.  Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line.

Authors:  N H Hunt; M Ellison; J C Underwood; T J Martin
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

View more
  75 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  Effect of Pasteurella multocida toxin on bone resorption in vitro.

Authors:  R Felix; H Fleisch; P L Frandsen
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

Review 3.  Hormonal regulation and implication of cell signaling in calcium transfer by placenta.

Authors:  J Lafond; I Goyer-O'Reilly; M Laramée; L Simoneau
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

4.  Oral calcitonin.

Authors:  Michael J Maricic
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 5.  Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

6.  Production and characterization of new monoclonal antibodies to human osteoclasts.

Authors:  P N Nelson; J A Pringle; T J Chambers
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

7.  Partial characterization of rat marrow stromal cells.

Authors:  D J Simmons; P Seitz; L Kidder; G L Klein; M Waeltz; C M Gundberg; C Tabuchi; C Yang; R W Zhang
Journal:  Calcif Tissue Int       Date:  1991-05       Impact factor: 4.333

Review 8.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

9.  Carbonic anhydrase II gene transcript in cultured osteoclasts from neonatal rats: effect of calcitonin.

Authors:  M H Zheng; Y Fan; S Wysocki; D J Wood; J M Papadimitriou
Journal:  Cell Tissue Res       Date:  1994-04       Impact factor: 5.249

10.  Reversible calcitonin binding to solubilized sheep brain binding sites.

Authors:  P M Sexton; H G Schneider; C S D'Santos; F A Mendelsohn; B E Kemp; J M Moseley; T J Martin; D M Findlay
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.